After treatment of GC cells with 5FU and loganetin, several key proteins in the WNT/β‐catenin signalling pathway and its downstream targets including c‐myc, Met and CD44 were down‐regulated (Figure 4B). The gene discussed is MET; the disease is gastric cancer.